Therefore, septin4-K174R (mimicking deacetylation via SIRT2) may be a new target for alleviating renal injury in hypertension (47), which may help design precise therapeutic regimens and develop targeted drugs in the future. This evidence concerns the gene SEPTIN4 and Hypertension.